Suppr超能文献

来自结节漏斗神经元的内源性多巴胺释放:钙调蛋白起作用吗?

Endogenous dopamine release from tuberoinfundibular neurons: does calmodulin play any role?

作者信息

Di Renzo G F, Amoroso S, Taglialatela M, Annunziato L

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):224-8. doi: 10.1007/BF00512933.

Abstract

The possible involvement of calmodulin in the process of endogenous dopamine (DA) release from arcuate-periventricular nuclei-median eminence fragments, containing tuberoinfundibular dopaminergic (TIDA) neurons, has been investigated in an in vitro incubation system. For this purpose the basal and K+-stimulated DA release was examined in the presence and in the absence of the different putative calmodulin antagonists, pimozide, trifluoperazine, penfluridol and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7). Trifluoperazine and pimozide in concentrations up to 100 microM were both uneffective in blocking K+-evoked DA release. Penfluridol in doses of 5 and 10 microM, did not prevent 35 mM K+-induced endogenous DA release. It was able to reduce K+-stimulated DA release only at the very large concentration of 100 microM. W-7 added in vitro to the hypothalamic fragments, prevented endogenous DA release evoked by 35 mM K+ in a dose-dependent manner. W-5, a chlorine deficient analogue of W-7, that interacts only weakly with calmodulin, failed to modify K+-stimulated endogenous DA release in doses up to 200 microM. All the putative calmodulin antagonists used in the present study did not induce any change of basal DA release. In conclusion the fact that most of the agents, except W-7, known to antagonize calmodulin-dependent processes in many biological systems failed to interfere with the release of endogenous DA from TIDA neurons seems to suggest that calmodulin does not play a crucial role in the process of DA release and that the inhibitory effect of W-7 on endogenous DA release may be better attributed to other mechanisms different from its anticalmodulin action.

摘要

在体外孵育系统中,研究了钙调蛋白在含结节漏斗多巴胺能(TIDA)神经元的弓状-室周核-正中隆起片段内源性多巴胺(DA)释放过程中可能的参与情况。为此,在存在和不存在不同假定的钙调蛋白拮抗剂匹莫齐特、三氟拉嗪、五氟利多和N-(6-氨基己基)-5-氯-1-萘磺酰胺(W-7)的情况下,检测基础和K⁺刺激的DA释放。浓度高达100 μM的三氟拉嗪和匹莫齐特均不能有效阻断K⁺诱发的DA释放。5 μM和10 μM剂量的五氟利多不能阻止35 mM K⁺诱导的内源性DA释放。仅在100 μM的极高浓度下,它才能减少K⁺刺激的DA释放。体外添加到下丘脑片段中的W-7以剂量依赖的方式阻止了35 mM K⁺诱发的内源性DA释放。W-5是W-7的缺氯类似物,与钙调蛋白的相互作用较弱,在高达200 μM的剂量下未能改变K⁺刺激的内源性DA释放。本研究中使用的所有假定的钙调蛋白拮抗剂均未引起基础DA释放的任何变化。总之,除W-7外,已知在许多生物系统中拮抗钙调蛋白依赖性过程的大多数药物未能干扰TIDA神经元内源性DA的释放,这一事实似乎表明钙调蛋白在DA释放过程中不发挥关键作用,并且W-7对内源性DA释放的抑制作用可能更好地归因于与其抗钙调蛋白作用不同的其他机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验